TRCT
NGVT icon

Tower Research Capital (TRC)’s Ingevity NGVT Stock Holding History

Tower Research Capital (TRC)’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$200K Buy
2,809
+497
+21% +$34K 0.01% 1615
2025
Q4 		$137K Sell
2,312
-1,297
-36% -$70.4K ﹤0.01% 1732
2025
Q3 		$199K Sell
3,609
-167
-4% -$8.69K 0.01% 1459
2025
Q2 		$163K Buy
3,776
+2,646
+234% +$102K ﹤0.01% 1975
2025
Q1 		$44.7K Sell
1,130
-448
-28% -$19.8K ﹤0.01% 2299
2024
Q4 		$64.3K Sell
1,578
-5,379
-77% -$224K ﹤0.01% 2398
2024
Q3 		$271K Buy
6,957
+462
+7% +$18.4K 0.01% 1344
2024
Q2 		$284K Buy
6,495
+2,299
+55% +$111K ﹤0.01% 1815
2024
Q1 		$200K Sell
4,196
-15,646
-79% -$703K ﹤0.01% 1410
2023
Q4 		$937K Buy
19,842
+18,840
+1,880% +$783K 0.01% 896
2023
Q3 		$47.7K Sell
1,002
-424
-30% -$23.1K ﹤0.01% 2584
2023
Q2 		$82.9K Sell
1,426
-195
-12% -$11.7K ﹤0.01% 2173
2023
Q1 		$116K Buy
1,621
+607
+60% +$48.2K ﹤0.01% 1732
2022
Q4 		$72K Sell
1,014
-2,716
-73% -$191K ﹤0.01% 2085
2022
Q3 		$226K Buy
3,730
+1,591
+74% +$107K ﹤0.01% 1812
2022
Q2 		$135K Sell
2,139
-1,809
-46% -$118K ﹤0.01% 2060
2022
Q1 		$253K Buy
3,948
+56
+1% +$3.75K ﹤0.01% 1571
2021
Q4 		$279K Sell
3,892
-4,124
-51% -$314K ﹤0.01% 1523
2021
Q3 		$572K Buy
8,016
+4,201
+110% +$331K 0.01% 888
2021
Q2 		$310K Sell
3,815
-10,252
-73% -$825K 0.01% 1581
2021
Q1 		$1.06M Buy
14,067
+9,610
+216% +$700K 0.02% 751
2020
Q4 		$337K Sell
4,457
-51,093
-92% -$3.33M 0.01% 1310
2020
Q3 		$2.75M Buy
55,550
+37,635
+210% +$2.12M 0.03% 235
2020
Q2 		$942K Buy
+17,915
New +$850K 0.04% 566
2020
Q1 		– Sell
-309
Closed -$27K – 3601
2019
Q4 		$27K Sell
309
-2,548
-89% -$223K ﹤0.01% 1737
2019
Q3 		$243K Buy
2,857
+2,217
+346% +$198K 0.02% 905
2019
Q2 		$67K Buy
640
+23
+4% +$2.31K ﹤0.01% 1415
2019
Q1 		$65K Buy
+617
New +$62K ﹤0.01% 1641
2018
Q4 		– Sell
-283
Closed -$29K – 4175
2018
Q3 		$29K Sell
283
-1,284
-82% -$124K ﹤0.01% 2097
2018
Q2 		$127K Sell
1,567
-4,593
-75% -$365K 0.01% 1290
2018
Q1 		$454K Buy
+6,160
New +$461K 0.04% 522
2017
Q4 		– Sell
-6,852
Closed -$428K – 3835
2017
Q3 		$428K Buy
+6,852
New +$406K 0.04% 311
2016
Q4 		– Sell
-300
Closed -$14K – 4208
2016
Q3 		$14K Sell
300
-2,449
-89% -$103K ﹤0.01% 1836
2016
Q2 		$94K Buy
+2,749
New +$85.8K 0.01% 1141

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Tower Research Capital (TRC)'s NGVT Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Ingevity (NGVT) stake by 21% in Q1 2026, buying an estimated $34K and bringing the position to 2,809 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #1615.

Tower Research Capital (TRC) first reported a position in NGVT in Q2 2016 and has held it in 34 quarters since. The position peaked at $2.75M in Q3 2020. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Tower Research Capital (TRC) held 2,809 shares of Ingevity worth $200K as of Q1 2026.
  • Tower Research Capital (TRC) bought 497 Ingevity shares in Q1 2026, an estimated $34K.
  • Ingevity made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1615 holding.
  • Tower Research Capital (TRC) first reported a position in Ingevity in Q2 2016 and has held it in 34 quarters since.
  • Tower Research Capital (TRC)'s Ingevity position peaked at $2.75M in Q3 2020.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.